T follicular helper cells in autoimmune diseases

X Wei, X Niu - Journal of Autoimmunity, 2023 - Elsevier
T follicular helper (Tfh) cells with the phenotype of mainly expressing surface molecules
CXC motif chemokine receptor type 5 (CXCR5), inducible co-stimulator (ICOS), secreting …

[HTML][HTML] B cells in head and neck squamous cell carcinoma: current opinion and novel therapy

X Guo, L Xu, L Nie, C Zhang, Y Liu, R Zhao… - Cancer Cell …, 2024 - Springer
Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumour. Despite
advancements in surgery, radiotherapy and chemotherapy, which have improved the …

Treatable traits in systemic sclerosis

F Amati, G Bongiovanni, A Tonutti, F Motta… - Clinical Reviews in …, 2023 - Springer
Systemic sclerosis (SSc) is a chronic systemic disease within the spectrum of connective
tissue diseases, specifically characterized by vascular abnormalities and inflammatory and …

Cancer incidence in Familial Mediterranean Fever: A retrospective analysis

SN Baspinar, B Kilic, FN Azman, Y Guler… - Seminars in Arthritis and …, 2023 - Elsevier
Abstract Objectives Familial Mediterranean Fever (FMF) is the most common hereditary
monogenic fever syndrome that is characterized by recurrent attacks of fever and …

[HTML][HTML] SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis

HY Jeong, JS Park, JS Woo, KH Lee, JW Choi… - Journal of …, 2023 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) induces a dysfunctional
immune response, inflammation, autoantibody production, and coagulopathy, which are …

Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma

Y Yu, C Liang, Q Tang, Y Shi, L Shen - Gene, 2024 - Elsevier
Background m6A regulators have important roles in a variety of autoimmune diseases, but
their potential function in scleroderma, a refractory connective tissue disease, remains …

[HTML][HTML] Umbilical-cord-derived mesenchymal stromal cells modulate 26 out of 41 T cell subsets from systemic sclerosis patients

P Laranjeira, F Dos Santos, MJ Salvador, IN Simões… - Biomedicines, 2023 - mdpi.com
Systemic sclerosis (SSc) is an immune-mediated disease wherein T cells are particularly
implicated, presenting a poor prognosis and limited therapeutic options. Thus, mesenchymal …

[HTML][HTML] Impaired regulation by IL-35 in systemic sclerosis

R Osuna-Gómez, I Castellví, M Mulet, MÀ Ortiz… - International Journal of …, 2023 - mdpi.com
This study investigated the role of IL-35 in systemic sclerosis (SSc) patients, focusing on
CD4+ T cell response and immunomodulatory cytokine production. By comparing the …

[HTML][HTML] Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis

O Gumkowska-Sroka, K Kotyla, E Mojs, K Palka… - Pharmaceuticals, 2023 - mdpi.com
Systemic sclerosis is a connective tissue disease of unknown origin and with an
unpredictable course, with both cutaneous and internal organ manifestations. Despite the …

Distribution and chemotactic mechanism of CD4+ T cells in traumatic tracheal stenosis

T Feng, Y Chen, J Wei, S Tan… - Immunity, Inflammation …, 2023 - Wiley Online Library
A systemic and local inflammatory immune imbalance is thought to be the cause of traumatic
tracheal stenosis (TS). However, with CD4+ T lymphocytes being the predominant immune …